• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.16% Nasdaq Down 0.08%

    Epizyme, Inc. (EPZM)

    -NasdaqGS
    22.71 Down 0.57(2.45%) Jul 2, 4:00PM EDT
    Add to Portfolio
    Prev Close:23.28
    Open:23.23
    Bid:21.28 x 200
    Ask:N/A
    1y Target Est:38.67
    Beta:1.25
    Earnings Date:Aug 11 - Aug 17 (Est.)
    Day's Range:22.54 - 23.47
    52wk Range:15.51 - 40.98
    Volume:340,914
    Avg Vol (3m):425,271
    Market Cap:935.77M
    P/E (ttm):N/A
    EPS (ttm):-3.22
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for EPZM

    Comparison

    Symbol% ChgMkt Cap
    EPZMDown 2.45%935.77M
    GSKUp 0.28%102.06B
    NVSUp 1.30%241.55B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):33.16
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-4.13
    Quarterly EPS Est (Jun-15) :-0.74
    Mean Recommendation*:1.9
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Epizyme, Inc., a clinical stage biopharmaceutical company, discovers and develops epigenetic therapies for cancer patients. Its proprietary product platform creates small molecule inhibitors of a 96-member class of enzymes known as histone methylt... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback